Skip to content

Effect of ultrasound-guided pulmonary dilatation on early atelectasis in patients undergoing thoracoscopic lung surgery: a prospective, randomized, controlled study

Effect of ultrasound-guided pulmonary dilatation on early atelectasis in patients undergoing thoracoscopic lung surgery: a prospective, randomized, controlled study

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400087022
Enrollment
Unknown
Registered
2024-07-17
Start date
2023-03-07
Completion date
Unknown
Last updated
2024-07-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pulmonary disease

Interventions

Ultrasound-guided lung recruitment group:Real-time ultrasound-guided lung recruitment
pressure controlled recruitment group:Lung recruitment by pressure control method

Sponsors

West China Hospital, Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1)Age =18 years old 2)ASA: I-III 3)Selective thoracoscopic surgery requiring OLV under general anesthesia (excluding emergency surgery) 4) Sign informed consent

Exclusion criteria

Exclusion criteria: 1) For any reason, it is impossible to cooperate with the study or the researcher thinks that it is not suitable to be included in this experiment. 2) Preoperative history of lung surgery or uncontrollable asthma. 3) Adverse events listed as pulmonary complications before anesthesia induction (aspiration, moderate respiratory failure, pulmonary exudation, pulmonary infection, atelectasis, cardiogenic pulmonary edema, pleural effusion, pneumothorax, pulmonary embolism, purulent pleurisy and pulmonary hemorrhage). 4) COPD III and IV (GOLD grade), pulmonary fibrosis, pulmonary bullae, severe emphysema or pneumothorax. 5) Patients with cardiac insufficiency (NYHA cardiac function grade =3), previous history of cerebral infarction (previous hospitalization and treatment), intracranial hypertension, severe liver disease (such as liver cirrhosis with Child-Pugh score of B or C) or chronic renal failure (glomerular filtration rate < 30 ml/min). 6) Have participated in other clinical trials.

Design outcomes

Primary

MeasureTime frame
Incidence of atelectasis 30 minutes after tracheal extubation;

Secondary

MeasureTime frame
Lung ultrasound score 30 minutes after extubation;Maximum peak airway pressure during lung recruitment;Incidence of hypoxic events (SpO2?92%) in postoperative PACU;

Countries

China

Contacts

Public ContactYu Hai

West China Hospital of Sichuan University

yuhaishan117@yahoo.com+86 189 8060 1548

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026